Refine
Has Fulltext
- yes (30)
Is part of the Bibliography
- yes (30)
Document Type
- Journal article (29)
- Preprint (1)
Language
- English (30)
Keywords
- positron emission tomography (7)
- CXCR4 (6)
- PRRT (5)
- multiple myeloma (5)
- PET (4)
- PET/CT (4)
- lymphoma (4)
- FDG (3)
- chemokine receptor (3)
- medicine (3)
- molecular imaging (3)
- neuroendocrine tumor (3)
- theranostics (3)
- FDG-PET/CT (2)
- MAG3 (2)
- NET (2)
- PSMA (2)
- Positronen-Emissions-Tomografie (2)
- RADS (2)
- SSTR (2)
- SSTR-RADS (2)
- bone disease (2)
- in vivo imaging (2)
- involvement (2)
- peptide receptor radionuclide therapy (2)
- prostate cancer (2)
- 177Lu (1)
- 18-F-fluorothymidine uptake (1)
- 18FDG-PET/CT (1)
- 1st International Workshop (1)
- 5-Fluorouracil (1)
- 5IA-SPECT (1)
- 68Ga-DOTANOC (1)
- 68Ga-DOTATATE (1)
- 68Ga-DOTATOC (1)
- Arginine (1)
- B-cell lymphoma (1)
- BSS directive (1)
- CXCR4/SDF-1 (1)
- CYP11B enzymes (1)
- DLBCL (1)
- DNA repair (1)
- DOTATOC (1)
- FDG PET/CT (1)
- FDG-PET (1)
- FDG-PET/MRI (1)
- FLT-PET (1)
- Hodgkin-lymphoma (1)
- Hyperkalaemia (1)
- Lysine (1)
- MI-RADS (1)
- Merkel cell carcinoma (1)
- Molecular imaging (1)
- Multiple myeloma (1)
- NVP-BGT226 (1)
- PROMISE (1)
- PSMA-RADS (1)
- Parkinson disease (1)
- Parkinson’s disease (1)
- Positron emission tomography (1)
- Radium (1)
- SPECT (1)
- Somatostatin receptor expression (1)
- WB-DW-MRI (1)
- [18F]Fluorodeoxythymidine (1)
- [\(^{68}\)Ga] pentixafor (1)
- [\(^{68}\)Ga]Pentixafor (1)
- \(^{11}\)C-Methionine-PET (1)
- \(^{11}\)C-methionine (1)
- \(^{18}\)F-FDG PET/CT (1)
- \(^{68}\)Ga-Pentixafor (1)
- acute myeloid leukemia (1)
- adrenal incidentaloma (1)
- adrenocortical carcinoma (1)
- alpha-emitters (1)
- amino acids (1)
- autologous transplantation (1)
- bone-targeting radiopharmaceuticals (1)
- cancer (1)
- cardiac neurohormonal system (1)
- cells (1)
- chemokine receptor-4 (1)
- cholinergic activity (1)
- coefficient (1)
- cognitive decline (1)
- diffusion weighted MRI (1)
- dopamine acetylcholine (1)
- dosimetry (1)
- early response (1)
- endocrinology (1)
- esophagogastric junction (1)
- experience (1)
- folinic acid (1)
- follicular lymphoma (1)
- gemcitabine (1)
- glioblastoma (1)
- glioblastoma multiforme (1)
- glioma (1)
- heart failure (1)
- hyperkalemia (1)
- imaging (1)
- imaging proliferation (1)
- imaging techniques (1)
- immunostaining (1)
- in-vivo (1)
- inhibition (1)
- initial experience (1)
- irinotecan (1)
- kidney function (1)
- levodopa-induced dyskinesia (1)
- locally advanced disease (1)
- macrophages (1)
- magnetic resonance imaging (1)
- malignancies (1)
- malignant lymphoma (1)
- mammalian target of rapamycin (1)
- management (1)
- microenvironment (1)
- microglial cells (1)
- molecular medicine (1)
- nab-paclitaxel (1)
- neoadjuvant chemotherapy (1)
- neuroendocrine neoplasia (1)
- nicotinic receptors (1)
- non-Hodgkin's lymphoma (1)
- non-hodgkins-lymphoma (1)
- nuclear cardiology (1)
- nuclear medicine therapy (1)
- optimization (1)
- oxaliplatin (1)
- pancreatic cancer (1)
- phosphatidylinositol-3-kinase (1)
- pleural mesothelioma (1)
- positron emission tomography/computed tomography (1)
- prognostic value (1)
- prostate-specific membrane antigen (1)
- radionuclide therapy (1)
- radiotracer (1)
- recurrence (1)
- renal scintigraphy (1)
- reporting and data system (1)
- response evaluation (1)
- salvage radiotherapy (1)
- signaling pathway (1)
- somatostatin (1)
- somatostatin receptor (1)
- standardized reporting (1)
- stem-cell transplantation (1)
- survival (1)
- target (1)
- therapeutic target (1)
- treatment response (1)
- tumor (1)
- whole body MRI (1)
- whole-body (1)
Institute
- Klinik und Poliklinik für Nuklearmedizin (29)
- Medizinische Klinik und Poliklinik II (8)
- Pathologisches Institut (6)
- Abteilung für Molekulare Innere Medizin (in der Medizinischen Klinik und Poliklinik II) (2)
- Institut für Klinische Biochemie und Pathobiochemie (2)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (2)
- Medizinische Klinik und Poliklinik I (2)
- Neurologische Klinik und Poliklinik (2)
- Institut für Klinische Epidemiologie und Biometrie (1)
- Institut für Medizinische Strahlenkunde und Zellforschung (1)
Sonstige beteiligte Institutionen
EU-Project number / Contract (GA) number
- 701983 (2)
Heart failure is one of the growing causes of death especially in developed countries due to longer life expectancy. Although many pharmacological and instrumental therapeutic approaches have been introduced for prevention and treatment of heart failure, there are still limitations and challenges. Nuclear cardiology has experienced rapid growth in the last few decades, in particular the application of single photon emission computed tomography (SPECT) and positron emission tomography (PET), which allow non-invasive functional assessment of cardiac condition including neurohormonal systems involved in heart failure; its application has dramatically improved the capacity for fundamental research and clinical diagnosis. In this article, we review the current status of applying radionuclide technology in non-invasive imaging of neurohormonal system in the heart, especially focusing on the tracers that are currently available. A short discussion about disadvantages and perspectives is also included.